Please contact our Business Development team for any query







Medicinal Chemistry Preclinical Discovery

Medicinal Chemistry services at TCGLS offer specific solutions to integrated discovery projects across multiple therapeutic areas. Our team of experienced medicinal chemists, working closely with in- vitro pharmacologists, DMPK and in vivo pharmacologists and computational chemists have proven track record: to advance challenging discovery programs by emulating project goals/timelines through valuable decision making from Hit generation to preclinical candidate selection in multiple integrated projects


Designing of new molecular entities having preferred physicochemical properties either for novel target/s or a fast-follower program, are primarily done following:

  • Structure-guided drug design
  • Ligand-based approach, more specifically pharmacophore-based approach

Moreover, in silico screening of a commercially available library database (over 2 million) is also carried out to identify potential Hit molecules.

To answer key structure-activity relationship (SAR) and structure-property relationship (SPR) questions, synthesis of molecules are carried out either in singleton or library mode focusing on productivity and cycle time management with real-time problem solving with the help of state of the art infrastructure, compound management facility and scientific databases in support with smooth and hassle-free procurement and logistics.